摘要 |
The invention relates to oligosaccharides with the sequence GalNAc beta (1-4) (Fuc alpha (1-3) GlcNAc. They are produced by incubating Human Kidney 293 cells and isolating the novel oligosaccharides from the peptide produced. oligosaccharides can be used to act as high affinity ligands of certain cell adhesion receptors, and may be used to prevent or reduce cell adhesion and inflammation. |